This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hester, S. Articles by Styblo, M Search for Related Content PubMed PubMed Citation Articles by Hester, S. Articles by Styblo, M Social Bookmarking                         What's this?

Expression of AS3MT alters transcriptional profiles in human urothelial cells exposed to arsenite

Cancer Biology Branch, ECD, NHEERL, US EPA, RTP, North Carolina hester.susan{at}epa.gov

Z Drobná

Department of Nutrition, University of North Carolina, Chapel Hill, North Carolina

DMK Andrews

Microarray Core, NIEHS, RTP, North Carolina

J Liu

Inorganic Carcinogenesis, LCC, National Cancer Institute at NIEHS

MP Waalkes

Inorganic Carcinogenesis, LCC, National Cancer Institute at NIEHS

DJ Thomas

Pharmacokinetics Branch, ETD, NHEERL, US EPA, RTP, North Carolina

M Stblo

Department of Nutrition, University of North Carolina, Chapel Hill, North Carolina; Center for Environmental Medicine, Asthma, and Lung Biology; University of North Carolina, Chapel Hill, North Carolina

Inorganic arsenic (iAs) is an environmental toxicant and human carcinogen. The enzymatic methylation of iAs that is catalyzed by arsenic (+3 oxidation state)-methyltransferase (AS3MT) generates reactive methylated intermediates that contribute to the toxic and carcinogenic effects of iAs. We have shown that clonal human urothelial cells (UROtsa/F35) that express rat AS3MT and methylate iAs are more susceptible to acute toxicity of arsenite (iAs^III) than parental UROtsa cells that do not express AS3MT and do not methylate iAs. The current work examines transcriptional changes associated with AS3MT expression and identifies specific categories of genes expressed in UROtsa and UROtsa/F35 cells in response to a 24-h exposure to 1 or 50 µM iAs^III. Here, the expression of 21,073 genes was assessed using Agilent Human 1A(V2) arrays. Venn analysis showed marked concentration-dependent differences between gene expression patterns in UROtsa and UROTsa/F35 cells exposed to iAs^III. Among 134 genes altered by exposure to subtoxic 1 µM iAs^III, only 14 were shared by both cell lines. Exposure to cytotoxic 50 µM iAs^III uniquely altered 1389 genes in UROtsa/F35 and 649 genes in UROtsa cells; 5033 altered genes were associated with the chemical alone. In UROtsa, but not UROtsa/F35 cells exposure to 1 µM iAs^III altered expression of genes associated with cell adhesion. In contrast, expression of genes involved in cell cycle regulation was significantly altered in UROtsa/F35 cells at this exposure level. At 50 µM iAs^III, pathways regulating cell cycle, cell death, transcription, and metabolism were affected in both cell lines. However, only Urotsa/F35 cells showed numerous G-protein and kinase pathway alterations as well as alterations in pathways involved in cell growth and differentiation. These data link the AS3MT-catalyzed methylation of iAs to specific genomic responses in human cells exposed to iAs^III. Further analysis of these responses will help to characterize the role of AS3MT-catalyzed methylation in modulation of iAs^III toxicity.

Key Words: arsenite • AS3MT • human urothelial cells • transcriptional profiles

Human & Experimental Toxicology, Vol. 28, No. 1, 49-61 (2009)
DOI: 10.1177/0960327109102368


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. Kojima, D. C. Ramirez, E. J. Tokar, S. Himeno, Z. Drobna, M. Styblo, R. P. Mason, and M. P. Waalkes Requirement of Arsenic Biomethylation for Oxidative DNA Damage J Natl Cancer Inst, December 16, 2009; 101(24): 1670 - 1681. [Abstract] [Full Text] [PDF]